TickerHumSide-by-side comparison
Bristol-Myers Squibb vs Medtronic
As of Nov 12, 2026, P/E is 13.8x for Bristol-Myers Squibb vs 24.9x for Medtronic; P/S is 2.5x for Bristol-Myers Squibb vs 3.4x for Medtronic; revenue growth is 4.2% for Bristol-Myers Squibb vs 9.8% for Medtronic; net margin is 18.5% for Bristol-Myers Squibb vs 13.9% for Medtronic.
What stands out
- Bristol-Myers Squibb is cheaper on earnings: 13.8x P/E vs 24.9x for Medtronic.
- Medtronic carries less debt relative to equity: 0.51 vs 1.79 for Bristol-Myers Squibb.
- Bristol-Myers Squibb's shares did better over the past year: +28.2% vs +5.0% for Medtronic.
Key metrics
| Metric | BMY | MDT |
|---|---|---|
| Price | $62.32 | $100.99 |
| Market cap | $127.39B | $129.18B |
| P/E | 13.8x (#1) | 24.9x (#2) |
| P/S | 2.5x (#1) | 3.4x (#2) |
| Revenue growth | 4.2% (#2) | 9.8% (#1) |
| Operating margin | — | 18.1% (#1) |
| Net margin | 18.5% (#1) | 13.9% (#2) |
| Debt / equity | 1.79 (#2) | 0.51 (#1) |
| 1-year return | +28.2% (#1) | +5.0% (#2) |
| Research score | 69/100 (#1) | 63/100 (#2) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Bristol-Myers Squibb Company (BMY) — Drug Manufacturers—General
- Medtronic plc (MDT) — Medical Devices